Drug Approval | July 17, 2025
Shilpa Medicare receives EIR from USFDA for Unit VI, Bengaluru
This facility is capable of manufacturing, packaging, testing, storage and distribution of two types of complex dosage forms
This facility is capable of manufacturing, packaging, testing, storage and distribution of two types of complex dosage forms
The UK authorization is based on positive results from the Phase III OASIS-1, -2, and -3 trials
CuraTeQ Biologics receives approval for biosimilar Zefylti from UK’s MHRA
Trastuzumab specifically binds and inhibits the human epidermal growth factor receptor 2 (HER2) protein
Talicia is also approved and launched in the UAE and additional countries may accept UK MHRA approvals as a reference for their own marketing approval processes
Alkem Medtech to acquire 100% stake of Bombay Ortho
The launch follows the approval from the Medicines and Healthcare Products Regulatory Agency (MHRA), U.K.
MET-X, a novel metallo-beta-lactamase (MBL) inhibitor, has shown best-in-class performance in preclinical studies
Glenmark’s consolidated revenue was at Rs. 3,387.6 crore as against Rs. 2,506.7 crore recording an increase of 35.1% YoY
Dyrupeg will be available as 6 mg solution for injection in prefilled syringe and is intended for the reduction in the duration of neutropenia
Subscribe To Our Newsletter & Stay Updated
